home · filing · 0001564590-21-045202
8-K
filed August 19, 2021, 7:59 PM ET
ticker HSDT
CIK 0001610853
leadership
confidence high
sentiment negative
materiality 0.55
COO Joyce LaViscount resigns for good reason; Helius pays $442K severance
Solana Co
LaViscount's COO employment ended July 20, 2021; she resigned for good reason under her employment agreement.
Company pays $442,150 in 12 monthly installments of ~$36,846, plus 9 months of health insurance premiums.
Unvested stock options accelerated and are exercisable through October 18, 2022.
LaViscount remains subject to 12-month non-compete and non-solicitation covenants.
Separation agreement signed August 17, 2021; terms disclosed in Form 8-K.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Joyce LaViscount
Chief Operating Officer
Effective 2021-07-20
Filed August 19, 2021, 7:59 PM ET
the employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. (the “Company”) ended on July 20, 2021
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joyce LaViscount resigned as Chief Operating Officer at Solana Co.
Action resigned
Role Chief Operating Officer
Exact text from the filing
the employment of Joyce LaViscount, Chief Operating Officer of Helius Medical Technologies, Inc. (the “Company”) ended on July 20, 2021
View on SEC.gov
Source: SEC EDGAR
accession 0001564590-21-045202
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.